Long-Term Follow-Up of Stent Recipients in the SCAAR

DES and BMS recipients had similar rates of death and MI, and restenosis was substantially reduced in high-risk DES recipients.

The long-term safety of drug-eluting stents (DES) has been much debated. Previous findings from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) suggested an increase in late mortality in patients who received DES during 2003 and 2004 (JW Cardiol Feb 12 2007). Extending the study to include all patients who received a single stent from 2003 through 2006 has enabled researchers to perform more-powerful analyses of discrete outcomes.

Among the 47,967 stent recipients with complete baseline data, 10,294 received one DES and 18,659 received one bare-metal stent (BMS). During a mean follow-up of 2.7 years (range, 1–5 years), no significant difference in the combined or individual endpoints of death and MI was found between DES an…

Reviewing Author

Beat J. Meyer, MD

Disclosures

Leadership positions in professional societiesBern Heart Foundation (President); International Academy of Medicine, Bern, Switzerland (Director)

Beat J. Meyer, MD

Disclosures

Leadership positions in professional societiesBern Heart Foundation (President); International Academy of Medicine, Bern, Switzerland (Director)

Long-Term Follow-Up of Stent Recipients in the SCAAR

Topics

Reviewing Author